Innoviva (INVA) Operating Income (2010 - 2026)
Innoviva (INVA) posted Operating Income of $38.2 million for Q1 2026, up 376.02% on a QoQ basis from -$13.8 million in Q4 2025, and down 7.9% year-over-year from $41.4 million in Q1 2025.
Innoviva (INVA) Operating Income (2010 - 2026) Analysis & Trends
Innoviva's Operating Income history runs 17 years deep, the most recent figure standing at $38.2 million for Q1 2026.
- Quarterly Operating Income fell 7.9% year-over-year to $38.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $197.8 million (down 5.48% YoY) and the FY2025 annual result came in at $163.7 million, down 1.87% from the prior year.
- Operating Income was $38.2 million for Q1 2026 at Innoviva, up from -$13.8 million in the prior quarter.
- Across five years, Operating Income topped out at $131.3 million in Q3 2023 and bottomed at -$31.3 million in Q2 2023.
- A 5-year average of $28.5 million and a median of -$6.6 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income slumped 124.9% — and 2025, when it surged 346.51%.
- Innoviva's Operating Income stood at -$10.3 million in 2022, then soared by 36.31% to -$6.6 million in 2023, then tumbled by 60.22% to -$10.5 million in 2024, then slumped by 31.16% to -$13.8 million in 2025, then soared by 376.02% to $38.2 million in 2026.
- Business Quant data shows INVA's Operating Income at $38.2 million in Q1 2026, -$13.8 million in Q4 2025, and $124.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 38.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.15 Mn |
| Dec 31, 2025 | -13.82 Mn |
| Sep 30, 2025 | 124.76 Mn |
| Jun 30, 2025 | 48.75 Mn |
| Mar 31, 2025 | 41.43 Mn |
| Dec 31, 2024 | -10.54 Mn |
| Sep 30, 2024 | 123.73 Mn |
| Jun 30, 2024 | 54.69 Mn |
| Mar 31, 2024 | -16.81 Mn |
| Dec 31, 2023 | -6.58 Mn |
| Sep 30, 2023 | 131.30 Mn |
| Jun 30, 2023 | -31.30 Mn |
| Mar 31, 2023 | -21.67 Mn |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | 71.70 Mn |
| Jun 30, 2022 | -24.04 Mn |
| Mar 31, 2022 | -14.82 Mn |
| Dec 31, 2021 | -6.05 Mn |
| Sep 30, 2021 | 270.58 Mn |
| Jun 30, 2021 | 96.54 Mn |